Vanguard Fiduciary Trust
CODX

Vanguard Fiduciary Trust’s Co-Diagnostics CODX Stock Holding History

Vanguard Fiduciary Trust’s Portfolio CODX Stock Details CODX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$61.3K Buy
19,776
+19,775
+1,977,500% +$60.8K ﹤0.01% 3827
2026
Q1 		$2 Buy
+1
New +$3 ﹤0.01% 4063

Other funds holding CODX

AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PAG
Private Advisory Group Redmond, Washington $1.85B AUM 50.66% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Fiduciary Trust's CODX Position: Q2 2026 in Review

Vanguard Fiduciary Trust increased its Co-Diagnostics (CODX) stake by 1,977,500% in Q2 2026, buying an estimated $60.8K and bringing the position to 19,776 shares worth $61.3K. The position accounts for ﹤0.01% of the portfolio, ranked #3827.

Vanguard Fiduciary Trust first reported a position in CODX in Q1 2026 and has held it in 2 quarters since. 24 funds tracked by Wall St. Rank hold CODX as of Q2 2026.

  • Vanguard Fiduciary Trust held 19,776 shares of Co-Diagnostics worth $61.3K as of Q2 2026.
  • Vanguard Fiduciary Trust bought 19,775 Co-Diagnostics shares in Q2 2026, an estimated $60.8K.
  • Co-Diagnostics made up ﹤0.01% of Vanguard Fiduciary Trust's portfolio in Q2 2026, its #3827 holding.
  • Vanguard Fiduciary Trust first reported a position in Co-Diagnostics in Q1 2026 and has held it in 2 quarters since.
  • 24 funds tracked by Wall St. Rank held Co-Diagnostics as of Q2 2026.

Based on Vanguard Fiduciary Trust's 13F filing for Q2 2026, filed 13 Aug 2026.